MOUNTAIN VIEW, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a ...
WASHINGTON, Oct. 27, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the global leader in non-invasive artificial intelligence (AI) heart care solutions, today announced seven-year data confirming the use ...
Patients who present to the emergency department (ED) with acute chest pain can benefit from the added information provided by CT-derived fractional flow reserve (FFRCT), a single-center experience ...
Using coronary CT angiography (CTA) to derive fractional flow reserve (FFR) values in patients with stable chest pain leads clinicians to rethink their management plans two-thirds of the time compared ...
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service ...
Hosted on MSN
HeartFlow Q1 earnings call highlights
Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its ...
2025 JUL 17 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Researchers detail new data in Cardiovascular Research. According to news reporting out of Tokyo, Japan, by ...
According to results of the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource Impacts) trial, a test known as FFRCT can obviate the need for invasive tests in up to 61% of ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc. today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment Classification (APC) ...
Please provide your email address to receive an email when new articles are posted on . The ability to make more accurate diagnoses while minimizing invasiveness, cost and patient risk is an important ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc. has announced the approval of its HeartFlow® FFRct Analysis by the Japanese Ministry of Health, Labour and Welfare (MHLW). The HeartFlow FFRct ...
Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease Seven-year follow-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results